The global atrial fibrillation (Afib) Market is witnessing significant momentum as rising cardiovascular disease prevalence, an aging population, and technological advancements drive demand for innovative treatment solutions. With Afib being the most common sustained cardiac arrhythmia worldwide, healthcare systems and companies are increasingly prioritizing new therapies, devices, and digital...
English
العربية
Français
Español
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt